Complement in inflammatory tissue damage and disease

Trends in Immunology

Volumn 23, Issue 2, 2002, Pages 61-64

  Mollnes, Tom E ^a   Song, Wen Chao ^b   Lambris, John D ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD59 ANTIGEN; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3D RECEPTOR; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT COMPONENT C5A RECEPTOR ANTAGONIST; COMPLEMENT FACTOR H; COMPLEMENT INHIBITOR; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 1 RELATED PROTEIN Y; CREATINE KINASE MB; DECAY ACCELERATING FACTOR; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL GLYCAN CLASS A; PROTEIN; TROPONIN T; UNCLASSIFIED DRUG;

ANGIONEUROTIC EDEMA; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; CLINICAL TRIAL; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; COMPLEMENT SYSTEM; CONFERENCE PAPER; DISEASE PREDISPOSITION; DRUG EFFECT; GENETIC DISORDER; HEART INFARCTION; HEMOGLOBINURIA; HOMEOSTASIS; HUMAN; HYPERSENSITIVITY; NEPHRITIS; NONHUMAN; PHAGOCYTOSIS; REPERFUSION INJURY; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE INJURY;

ANIMALS; COMPLEMENT SYSTEM PROTEINS; GREECE; HUMANS; HYPERSENSITIVITY; IMMUNITY; IMMUNITY, ACTIVE; INFLAMMATION;

EID: 0036476029     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4906(01)02129-9     Document Type: Conference Paper

References (31)

1. A hierarchical role for classical-pathway complement proteins in the clearance of apoptotic cells in vivo
2. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5
3. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting
4. A critical role for murine complement regulator Crry in fetomaternal tolerance
5. Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria
6. Increased susceptibility of decay-accelerating-factor-deficient mice to antiglomerular basement-membrane glomerulonephritis
7. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity
8. Antibody response to a T-dependent antigen requires B-cell expression of complement receptors
9. Regulation of B-lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex
10. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T-cell recruitment
11. A role for the C3a anaphylatoxin receptor in the effector phase of asthma
12. Cutting edge: Guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: Evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma
13. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis
14. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement
15. Inhibition of mannose-binding lectin reduces postischemic myocardial reperfusion injury
16. Predominant role for C5b-9 in renal ischemia/reperfusion injury
17. Intestinal ischemia-reperfusion injury is mediated by the membrane attack complex
18. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia reperfusion injury
19. Recombinant human complement C5A receptor antagonist reduces infarct size after surgical revascularization
20. Effects of complement activation in the isolated heart - Role of the terminal complement components
21. Sublytic complement attack reduces infarct size in rabbit isolated hearts: Evidence for C5a-mediated cardioprotection
22. Synthetic peptides which inhibit the interaction between C1q and immunoglobulin and prolong xenograft survival
23. C1-inhibitor: An anti-inflammatory reagent with therapeutic potential
24. Inhibition of complement, neutrophil and platelet activation by an anti-factor-D monoclonal antibody in simulated cardiopulmonary bypass circuits
25. Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome
26. Compstatin, a peptide inhibitor of C3, prolongs survival of ex-vivo-perfused pig xenografts
27. Inhibition of heparin/protamine-complex-induced complement activation by Compstatin in baboons
28. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass
29. Protective effects of C5a blockade in sepsis
30. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models
31. A new small molecule C5a receptor antagonist inhibits the reverse-passive arthus reaction and endotoxic shock in rats